Építés alatt – nem éles oldal
Belépés
Résztvevőt keres itt: Egyesült ÁllamokFázis nélkül

Seated Balance Using the Indego™

A legfontosabb adatok

Ki végzi
James J. Peters Veterans Affairs Medical Center
Hol
The Bronx (Egyesült Államok)A helyszín megnézése
Azonosító
Állapot
Toboroz
Résztvevők
20 fő, tervezett
Kezdés
2018. febr. 1.
Tervezett befejezés
2025. dec. 31.
A vizsgálat típusa
Beavatkozással járó
A vizsgált kezelések
  • Indego™ Exoskeleton
A regiszteradat frissítve
2025. május 14.

Ki vehet részt

MI-összefoglaló

A vizsgálat saját részvételi feltételeiből. Gép olvasta ki az oldalon álló regiszterszövegből, ezért tévedhet. Hogy ki vehet részt, azt a lenti regiszterszöveg és a vizsgálat csapata dönti el.

The trial is looking for adults with a spinal cord injury at T4 or below who use a wheelchair. They will train walking with the Indego™ exoskeleton, a wearable robotic device, to see if it improves balance while sitting.

Életkor
18 years and older.
Nem
All sexes can join.
A betegség stádiuma
Traumatic or non-traumatic spinal cord injury for at least 6 months. Injury level T4 and below, complete or incomplete (ISNCSCI A to D). Uses a wheelchair indoors and outdoors. Must be able to hold crutches, with or without changes to them.
Korábbi kezelés
Cannot join if using medicines that lower the seizure threshold, such as tricyclic antidepressants, amphetamines, neuroleptics, dalfampridine and bupropion.
Biomarker vagy leletérték
Knee BMD (bone density) must not be below 0.60 gm/cm2. Total hip BMD T-score must not be below -3.5.

A részvétel fő kizáró okai

  • Other nerve injury besides spinal cord injury, a worsening nerve condition, or history of seizure, stroke, brain tumor or multiple sclerosis.
  • Leg fracture from trauma in the past 2 years, any low-impact leg fracture since the injury, or a foot fracture.
  • Body size, stiff joints or ankle limits that do not fit the device.
  • Uncontrolled high blood pressure, or a current pressure sore on the arms, trunk, pelvis or legs.
  • Pregnancy or planning pregnancy, or implants such as a pacemaker, nerve stimulator or metal implants.

A regiszter feltételei, szó szerint

Mind a 27 feltétel megnézéseKevesebb

Ki vehet részt

  • Traumatic or non-traumatic SCI ≥6 months duration of SCI
  • Wheelchair-user for indoor and outdoor mobility
  • Level and completeness of injury T4 and below with complete or incomplete SCI (ISNCSCI A to D)
  • Able to hold the crutches in hands with or without modifications; and
  • Able to provide informed consent

Ki nem vehet részt

  • Severe concurrent medical disease, illness or condition judged to be contraindicated by the Site Physician
  • History of moderate or severe head trauma (loss of consciousness for greater than one hour or evidence of brain contusion or hemorrhage or depressed skull fracture on prior imaging)
  • Progressive condition that would be expected to result in changing neurological status
  • Untreated or uncontrolled hypertension (systolic blood pressure >140 mmHg; diastolic blood pressure >90 mmHg)
  • Current pressure ulcer of the arms, trunk, pelvic area, or lower extremities
  • History of seizure
  • Use of medications that significantly lower seizure threshold, such as tricyclic antidepressants, amphetamines, neuroleptics, dalfampridine, and bupropion
  • History of stroke, brain tumor, brain abscess, or multiple sclerosis
  • History of implanted brain/spine/nerve simulators, aneurysm clips, ferromagnetic metallic implants, or cardiac pacemaker/defibrillator
  • Diagnosis of neurological injury other than SCI
  • Anthropocentric incompatibility to be fitted with the device
  • Traumatic or high impact lower extremity fracture within the past 2 years
  • Fragility, minimal trauma or low impact fracture of the lower extremity since spinal cord injury
  • Knee BMD < 0.60 gm/cm2
  • Total hip BMD T-scores < -3.5
  • Untreatable severe spasticity judged to be contraindicated by the Site Physician
  • Flexion contracture that is incompatible with the device
  • Limitations in ankle range of motion that cannot be adapted with an orthotic device (plantar flexion > 00)
  • Fracture of the foot by x-ray and confirmed by CT
  • Unresolved orthostatic hypotension (systolic blood pressure <90 mmHg; diastolic blood pressure <60 mmHg) as judged to be contraindicated by the Site Physician
  • Psychopathology documentation in the medical record or history that may conflict with study objectives; and/or
  • Pregnancy or women who plan to become pregnant during the study period

Ez a vizsgálat jelenleg itt érhető el: Egyesült Államok.

  • James J Peters VA Medical CenterThe Bronx, Egyesült ÁllamokContact: Steven Knezevic, MSRésztvevőt keres

A vizsgálatról

Mit akar kideríteni a vizsgálat

Exoskeleton-assisted walking (EAW) provides a new mobility option and appears to have potential therapeutic benefits for persons with SCI. However, present day technology is not sufficient to replace the wheelchair. During EAW, users stand upright, maintain static and dynamic balance by actively and passively stimulating trunk and lower limb muscles in a manner not challenged during wheelchair use. Preliminary results in our laboratory suggest that the indirect balance challenges and postural perturbations that result during EAW training transfer to better seated balance control, resulting in more independence during seated activities. The purpose of this pilot study is to determine the effects of EAW training on various measures of seated balance (primary outcomes) and body composition (secondary outcomes). Twenty people with SCI (T4 and below) who are wheelchair users for mobility and cannot walk independently will be recruited. The participants will receive 36 sessions of EAW training in 12 weeks. The outcomes will be evaluated pre (baseline) and post (24 and 36 sessions). If EAW devices can be demonstrated to help people with SCI have better seated balance, in addition to the other potential benefits that are being investigated elsewhere, then exoskeletons may have the possibility to be more readily accepted in the clinical, home environments, and by the insurance companies.

A vizsgálat csoportja

  • Exoskeleton UsersA vizsgált kezelés

    All participants will receive 36 sessions of supervised EAW training using Indego™ for 12 weeks (3 to 4 sessions per week, 4-6 hours per week). The goal is to complete all 36 sessions in 12 weeks, but allowing for a two-week carryover to accommodate schedule conflicts or missed sessions.

    Kezelés: Indego™ Exoskeleton

Kérdések a vizsgálat csapatának

  1. Milyen gyakran kell bejárnom, és egy-egy alkalom mennyi ideig tart?
  2. Megtérítik az utazási költséget?
  3. Megtarthatom a saját orvosomat?
  4. Mi történik, ha ki akarok lépni?

Contact the study team: see the registry record → Contacts and Locations

Oldal nyomtatása az orvosomnak

Adatok és források

Regiszteradat
Szerepel a ClinicalTrials.gov-on.
Hivatalos cím
"The Effects of Exoskeletal-Assisted Walking on Seated Balance Using the Indego™"
MI-összefoglaló
A vizsgálat saját részvételi feltételeiből. Gépi kiolvasás: 2026. november 14.
A regiszteradat frissítve
2025. május 14.